Search research articles
Contact Us
Filters
Showing results (61-70 of 73) with videos related to
Page
of 8
Sort By:
Geburtshilfe Und Frauenheilkunde
|
January 13, 2016
Erratum: Sarcoma of the Uterus. Guideline of the DGGG (S2k-Level, AWMF Registry No. 015/074, August 2015)
D Denschlag, F C Thiel, S Ackermann, et al.
Geburtshilfe Und Frauenheilkunde
|
December 8, 2015
Sarcoma of the Uterus. Guideline of the DGGG (S2k-Level, AWMF Registry No. 015/074, August 2015)
D Denschlag, F C Thiel, S Ackermann, et al.
Cancer Research
|
October 15, 1996
Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors
A S Lübbe, C Bergemann, H Riess, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 30, 2010
The influence of tumor- and treatment-related factors on the development of local recurrence in osteosarcoma after adequate surgery. An analysis of 1355 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols
D Andreou, S S Bielack, D Carrle, et al.
ESMO Open
|
April 10, 2026
A randomized clinical study comparing trabectedin combined with regional hyperthermia with trabectedin in patients with advanced soft tissue sarcoma: HyperTET, a German Interdisciplinary Sarcoma Group trial
G-E Schuebbe, Y Xu, L H Lindner, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 20, 2004
Cardiac safety of trastuzumab in combination with epirubicin and cyclophosphamide in women with metastatic breast cancer: results of a phase I trial
M Untch, H Eidtmann, A du Bois, et al.
RSC Advances
|
May 11, 2022
Characterization of aluminum, aluminum oxide and titanium dioxide nanomaterials using a combination of methods for particle surface and size analysis
B Krause, T Meyer, H Sieg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 23, 2014
Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study
E Van Cutsem, C Boni, J Tabernero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 9, 2005
Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986
C-H Köhne, E van Cutsem, J Wils, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 27, 2017
Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'
P Schöffski, A Wozniak, S Stacchiotti, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 73) with videos related to
Sort By:
Page
of 8
Geburtshilfe Und Frauenheilkunde
|
January 13, 2016
Erratum: Sarcoma of the Uterus. Guideline of the DGGG (S2k-Level, AWMF Registry No. 015/074, August 2015)
D Denschlag, F C Thiel, S Ackermann, et al.
Geburtshilfe Und Frauenheilkunde
|
December 8, 2015
Sarcoma of the Uterus. Guideline of the DGGG (S2k-Level, AWMF Registry No. 015/074, August 2015)
D Denschlag, F C Thiel, S Ackermann, et al.
Cancer Research
|
October 15, 1996
Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors
A S Lübbe, C Bergemann, H Riess, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 30, 2010
The influence of tumor- and treatment-related factors on the development of local recurrence in osteosarcoma after adequate surgery. An analysis of 1355 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols
D Andreou, S S Bielack, D Carrle, et al.
ESMO Open
|
April 10, 2026
A randomized clinical study comparing trabectedin combined with regional hyperthermia with trabectedin in patients with advanced soft tissue sarcoma: HyperTET, a German Interdisciplinary Sarcoma Group trial
G-E Schuebbe, Y Xu, L H Lindner, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 20, 2004
Cardiac safety of trastuzumab in combination with epirubicin and cyclophosphamide in women with metastatic breast cancer: results of a phase I trial
M Untch, H Eidtmann, A du Bois, et al.
RSC Advances
|
May 11, 2022
Characterization of aluminum, aluminum oxide and titanium dioxide nanomaterials using a combination of methods for particle surface and size analysis
B Krause, T Meyer, H Sieg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 23, 2014
Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study
E Van Cutsem, C Boni, J Tabernero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 9, 2005
Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986
C-H Köhne, E van Cutsem, J Wils, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 27, 2017
Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'
P Schöffski, A Wozniak, S Stacchiotti, et al.
Page
of 8